Patrick J Mcenany Catalyst Pharmaceuticals, Inc. (CPRX) insider trading activity

Patrick J Mcenany is Director of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 4.48 Million shares of CPRX, which is worth approximately $96.2 Million. The most recent transaction as insider was on Nov 20, 2024, when has been sold 72,500 shares (Common Stock, par value $0.001 per share) at a price of $21.29 per share, resulting in proceeds of $1,543,525. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.48M

0% 3M change

8.71% 12M change

Total Value Held $96.2 Million

PATRICK J MCENANY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 20 2024	SELL Open market or private sale	$1,543,525 $21.29 p/Share	72,500 Reduced 1.59%	4,478,169 Common Stock, par valu...
Nov 20 2024	BUY Exercise of conversion of derivative security	$256,650 $3.54 p/Share	72,500 Added 1.57%	4,550,669 Common Stock, par valu...
Nov 19 2024	SELL Open market or private sale	$2,083,930 $21.19 p/Share	98,345 Reduced 2.15%	4,478,169 Common Stock, par valu...
Nov 19 2024	BUY Exercise of conversion of derivative security	$348,141 $3.54 p/Share	98,345 Added 2.1%	4,576,514 Common Stock, par valu...
Nov 14 2024	SELL Open market or private sale	$971,246 $21.75 p/Share	44,655 Reduced 0.99%	4,478,169 Common Stock, par valu...
Nov 14 2024	BUY Exercise of conversion of derivative security	$158,078 $3.54 p/Share	44,655 Added 0.98%	4,522,824 Common Stock, par valu...
Nov 13 2024	SELL Open market or private sale	$2,125,650 $22.98 p/Share	92,500 Reduced 2.02%	4,478,169 Common Stock, par valu...
Nov 13 2024	BUY Exercise of conversion of derivative security	$327,450 $3.54 p/Share	92,500 Added 1.98%	4,570,669 Common Stock, par valu...
Nov 12 2024	SELL Open market or private sale	$6,107,220 $23.31 p/Share	262,000 Reduced 5.53%	4,478,169 Common Stock, par valu...
Nov 12 2024	BUY Exercise of conversion of derivative security	$990,360 $3.78 p/Share	262,000 Added 5.31%	4,670,169 Common Stock, par valu...
Nov 11 2024	SELL Open market or private sale	$5,416,500 $23.55 p/Share	230,000 Reduced 4.89%	4,478,169 Common Stock, par valu...
Nov 11 2024	BUY Exercise of conversion of derivative security	$922,300 $4.01 p/Share	230,000 Added 4.66%	4,708,169 Common Stock, par valu...
Aug 22 2024	SELL Bona fide gift	-	5,100 Reduced 0.11%	4,478,169 Common Stock, par valu...
Aug 15 2024	SELL Bona fide gift	-	45,000 Reduced 0.99%	4,483,269 Common Stock, par valu...
Jan 30 2024	BUY Exercise of conversion of derivative security	-	143,000 Added 3.06%	4,528,256 Common Stock, par valu...
Jan 02 2024	BUY Exercise of conversion of derivative security	$282,500 $1.13 p/Share	250,000 Added 5.39%	4,385,256 Common Stock, par valu...
Dec 27 2023	SELL Payment of exercise price or tax liability	-	10,362 Reduced 0.25%	4,135,256 Common Stock, par valu...
Dec 27 2023	BUY Exercise of conversion of derivative security	-	26,333 Added 0.63%	4,145,618 Common Stock, par valu...
May 16 2023	BUY Exercise of conversion of derivative security	$137,340 $0.79 p/Share	173,849 Added 4.05%	4,119,285 Common Stock, par valu...
May 15 2023	SELL Open market or private sale	$345,977 $13.23 p/Share	26,151 Reduced 0.66%	3,945,436 Common Stock, par valu...
May 15 2023	BUY Exercise of conversion of derivative security	$20,659 $0.79 p/Share	26,151 Added 0.65%	3,971,587 Common Stock, par valu...
Feb 15 2023	SELL Payment of exercise price or tax liability	-	14,204 Reduced 0.36%	3,945,436 Common Stock, par valu...
Feb 15 2023	BUY Exercise of conversion of derivative security	-	58,333 Added 1.45%	3,959,640 Common Stock, par valu...
Dec 29 2022	SELL Bona fide gift	-	10,000 Reduced 0.26%	3,901,307 Common Stock, par valu...
Dec 28 2022	SELL Bona fide gift	-	10,000 Reduced 0.26%	3,911,307 Common Stock, par valu...

PJM

Patrick J Mcenany

Director

Coral Gables, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Value

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Track Activities on CPRX

Account